-
1
-
-
33646568784
-
Patterns of cancer incidence, mortality, and prevalence across five continents: Defining priorities to reduce cancer disparities in different geographic regions of the world
-
Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: Defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006; 24: 2137-2150.
-
(2006)
J Clin Oncol
, vol.24
, pp. 2137-2150
-
-
Kamangar, F.1
Dores, G.M.2
Anderson, W.F.3
-
2
-
-
27744507676
-
Increasing incidence of colorectal cancer in Asia: Implications for screening
-
Sung JJ, Lau JY, Goh KL, Leung WK. Increasing incidence of colorectal cancer in Asia: Implications for screening. Lancet Oncol 2005; 6: 871-876.
-
(2005)
Lancet Oncol
, vol.6
, pp. 871-876
-
-
Sung, J.J.1
Lau, J.Y.2
Goh, K.L.3
Leung, W.K.4
-
3
-
-
0142166328
-
Cancer chemoprevention with dietary phytochemicals
-
Surh YJ. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 2003; 3: 768-780.
-
(2003)
Nat Rev Cancer
, vol.3
, pp. 768-780
-
-
Surh, Y.J.1
-
4
-
-
33751089572
-
Phytic acid: a phytochemical with complementary and alternative benefits
-
Bakewell S. Phytic acid: a phytochemical with complementary and alternative benefits. Cancer Biol Ther 2006; 5: 1134-1135.
-
(2006)
Cancer Biol Ther
, vol.5
, pp. 1134-1135
-
-
Bakewell, S.1
-
5
-
-
0024517059
-
Inositol hexaphosphate inhibits large intestinal cancer in F344 rats 5 months after induction by azoxymethane
-
Shamsuddin AM, Wah A. Inositol hexaphosphate inhibits large intestinal cancer in F344 rats 5 months after induction by azoxymethane. Carcinogenesis 1989; 10: 625-626.
-
(1989)
Carcinogenesis
, vol.10
, pp. 625-626
-
-
Shamsuddin, A.M.1
Wah, A.2
-
6
-
-
0029057655
-
Inositol hexaphosphate and inositol inhibits DMBA-induced rat mammary cancer
-
Vucenik I, Yang GY, Shamsuddin AM. Inositol hexaphosphate and inositol inhibits DMBA-induced rat mammary cancer. Carcinogenesis 1995; 16: 1055-1058.
-
(1995)
Carcinogenesis
, vol.16
, pp. 1055-1058
-
-
Vucenik, I.1
Yang, G.Y.2
Shamsuddin, A.M.3
-
7
-
-
0038732463
-
Phytic acid (IP6), novel broad-spectrum anti-neoplastic agent: a systematic review
-
Fox CH, Eberl M. Phytic acid (IP6), novel broad-spectrum anti-neoplastic agent: a systematic review. Complement Ther Med 2002; 10: 229-234.
-
(2002)
Complement Ther Med
, vol.10
, pp. 229-234
-
-
Fox, C.H.1
Eberl, M.2
-
8
-
-
33751089572
-
Phytic acid: a phytochemical with complementary and alternative benefits
-
Bakewell S. Phytic acid: a phytochemical with complementary and alternative benefits. Cancer Biol Ther 2006; 5: 1134-1135.
-
(2006)
Cancer Biol Ther
, vol.5
, pp. 1134-1135
-
-
Bakewell, S.1
-
9
-
-
33750846875
-
Protection against cancer by dietary IP6 and inositol
-
Vucenik I, Shamsuddin AM. Protection against cancer by dietary IP6 and inositol. Nutr Cancer 2006; 55: 109-125.
-
(2006)
Nutr Cancer
, vol.55
, pp. 109-125
-
-
Vucenik, I.1
Shamsuddin, A.M.2
-
10
-
-
0242526048
-
Cancer inhibition by inositol hexaphosphate (IP6) and inositol: from laboratory to clinic
-
Vucenik I, Shamsuddin AM. Cancer inhibition by inositol hexaphosphate (IP6) and inositol: from laboratory to clinic. J Nutr 2003; 133: 3778S-3784S.
-
(2003)
J Nutr
, vol.133
, pp. 3778S-3784S
-
-
Vucenik, I.1
Shamsuddin, A.M.2
-
11
-
-
33750846875
-
Protection against cancer by dietary IP6 and inositol
-
Vucenik I, Shamsuddin AM. Protection against cancer by dietary IP6 and inositol. Nutr Cancer 2006; 55: 109-125.
-
(2006)
Nutr Cancer
, vol.55
, pp. 109-125
-
-
Vucenik, I.1
Shamsuddin, A.M.2
-
12
-
-
0345107253
-
Inositol hexaphosphate (IP6) inhibits key events of cancer metastasis: II. Effects on integrins and focal adhesions
-
Tantivejkul K, Vucenik I, Shamsuddin AM. Inositol hexaphosphate (IP6) inhibits key events of cancer metastasis: II. Effects on integrins and focal adhesions. Anticancer Res 2003; 23: 3681-3689.
-
(2003)
Anticancer Res
, vol.23
, pp. 3681-3689
-
-
Tantivejkul, K.1
Vucenik, I.2
Shamsuddin, A.M.3
-
14
-
-
0029415212
-
IP6-induced growth inhibition and differentiation of HT-29 human colon cancer cells: involvement of intracellular inositol phosphates
-
Yang GY, Shamsuddin AM. IP6-induced growth inhibition and differentiation of HT-29 human colon cancer cells: involvement of intracellular inositol phosphates. Anticancer Res 1995; 15: 2479-2487.
-
(1995)
Anticancer Res
, vol.15
, pp. 2479-2487
-
-
Yang, G.Y.1
Shamsuddin, A.M.2
-
15
-
-
0030499776
-
Novel anti-cancer functions of IP6: growth inhibition and differentiation of human mammary cancer cell lines in vitro
-
Shamsuddin AM, Yang GY, Vucenik I. Novel anti-cancer functions of IP6: growth inhibition and differentiation of human mammary cancer cell lines in vitro. Anticancer Res 1996; 16: 3287-3292.
-
(1996)
Anticancer Res
, vol.16
, pp. 3287-3292
-
-
Shamsuddin, A.M.1
Yang, G.Y.2
Vucenik, I.3
-
16
-
-
8844244745
-
Anti-angiogenic activity of inositol hexaphosphate (IP6)
-
Vucenik I, Passanti A, Vitolo MI, Tantivejkul K, Eggleton P, Shamsuddin AM. Anti-angiogenic activity of inositol hexaphosphate (IP6). Carcinogenesis 2004; 25: 2115-2123.
-
(2004)
Carcinogenesis
, vol.25
, pp. 2115-2123
-
-
Vucenik, I.1
Passanti, A.2
Vitolo, M.I.3
Tantivejkul, K.4
Eggleton, P.5
Shamsuddin, A.M.6
-
17
-
-
0030499776
-
Novel anticancer functions of IP6: growth inhibition and differentiation of human mammary cancer cell lines
-
Shamsuddin AM, Yang GY, Vucenik I. Novel anticancer functions of IP6: growth inhibition and differentiation of human mammary cancer cell lines. Anticancer Res 1996; 16: 3287-3292.
-
(1996)
Anticancer Res
, vol.16
, pp. 3287-3292
-
-
Shamsuddin, A.M.1
Yang, G.Y.2
Vucenik, I.3
-
18
-
-
0031858807
-
Up-regulation of the tumor suppressor gene p53 and WAF1 gene expression by IP6 in HT-29 human colon carcinoma cell line
-
Shamsuddin AM, Said IT. Up-regulation of the tumor suppressor gene p53 and WAF1 gene expression by IP6 in HT-29 human colon carcinoma cell line. Anticancer Res 1998; 18: 1479-1484.
-
(1998)
Anticancer Res
, vol.18
, pp. 1479-1484
-
-
Shamsuddin, A.M.1
Said, I.T.2
-
19
-
-
0034526276
-
Impairment of erbB1 receptor and fluid-phase endocytosis and associated mitogenic signaling by inositol hexaphosphate in human prostate carcinoma DU145 cells
-
Zi X, Singh RP, Agarwal R. Impairment of erbB1 receptor and fluid-phase endocytosis and associated mitogenic signaling by inositol hexaphosphate in human prostate carcinoma DU145 cells. Carcinogenesis 2000; 21: 2225-2235.
-
(2000)
Carcinogenesis
, vol.21
, pp. 2225-2235
-
-
Zi, X.1
Singh, R.P.2
Agarwal, R.3
-
20
-
-
0345305275
-
Inositol hexaphosphate inhibits constitutive activation of NF-kappa B in androgen-independent human prostate carcinoma DU145 cells
-
Agarwal C, Dhanalakshmi S, Singh RP, Agarwal R. Inositol hexaphosphate inhibits constitutive activation of NF-kappa B in androgen-independent human prostate carcinoma DU145 cells. Anticancer Res 2003; 23: 3855-3861.
-
(2003)
Anticancer Res
, vol.23
, pp. 3855-3861
-
-
Agarwal, C.1
Dhanalakshmi, S.2
Singh, R.P.3
Agarwal, R.4
-
21
-
-
84888881066
-
Pro-apoptotic effect of rice braninositol hexaphosphate (IP6) on HT-29 colorectal cancer cells
-
Shafie NH, Esa NM, Ithnin H, Saad H, Pandurangan AK. Pro-apoptotic effect of rice braninositol hexaphosphate (IP6) on HT-29 colorectal cancer cells. Int J Mol Sci 2013; 14: 23545-23558.
-
(2013)
Int J Mol Sci
, vol.14
, pp. 23545-23558
-
-
Shafie, N.H.1
Esa, N.M.2
Ithnin, H.3
Saad, H.4
Pandurangan, A.K.5
-
22
-
-
77952311165
-
Novel Expression Patterns of PI3K/AKT/mTOR Signaling Pathway
-
Johnson SM, Gulhati P, Rampy BA, Han Y, Rychahou PG, Doan HQ, Weiss HL, Evers BM. Novel Expression Patterns of PI3K/AKT/mTOR Signaling Pathway. J Am Coll Surg 2010; 210: 767-778.
-
(2010)
J Am Coll Surg
, vol.210
, pp. 767-778
-
-
Johnson, S.M.1
Gulhati, P.2
Rampy, B.A.3
Han, Y.4
Rychahou, P.G.5
Doan, H.Q.6
Weiss, H.L.7
Evers, B.M.8
-
23
-
-
0042631357
-
Combined- modality treatment of solid tumors using radiotherapy and molecular targeted agents
-
Ma BB, Bristow RG, Kim J and Siu LL. Combined- modality treatment of solid tumors using radiotherapy and molecular targeted agents. J Clin Oncol 2003; 21: 2760-2776.
-
(2003)
J Clin Oncol
, vol.21
, pp. 2760-2776
-
-
Ma, B.B.1
Bristow, R.G.2
Kim, J.3
Siu, L.L.4
-
24
-
-
31544444486
-
Phosphatidylinositol 3-kinase inhibition by LY294002 radiosensitizes human cervical cancer cell lines
-
Lee CM, Fuhrman CB, Planelles V, Peltier MR, Gaffney DK, Soisson AP, Dodson MK, Tolley HD, Green CL, Zempolich KA. Phosphatidylinositol 3-kinase inhibition by LY294002 radiosensitizes human cervical cancer cell lines. Clin Cancer Res 2006; 12: 250-256.
-
(2006)
Clin Cancer Res
, vol.12
, pp. 250-256
-
-
Lee, C.M.1
Fuhrman, C.B.2
Planelles, V.3
Peltier, M.R.4
Gaffney, D.K.5
Soisson, A.P.6
Dodson, M.K.7
Tolley, H.D.8
Green, C.L.9
Zempolich, K.A.10
-
25
-
-
33745307617
-
PI(3)K and mTOR signalling controls tumour cell growth
-
Shaw RJ, Cantley LC. PI(3)K and mTOR signalling controls tumour cell growth. Nature 2006; 441: 424-430.
-
(2006)
Nature
, vol.441
, pp. 424-430
-
-
Shaw, R.J.1
Cantley, L.C.2
-
26
-
-
0032053709
-
Mechanisms and consequences of activation of protein kinase B/Akt
-
Downward J. Mechanisms and consequences of activation of protein kinase B/Akt. Curr Opin Cell Biol 1998; 10: 262-267.
-
(1998)
Curr Opin Cell Biol
, vol.10
, pp. 262-267
-
-
Downward, J.1
-
27
-
-
57549101230
-
Small-molecule inhibitors of PDK1
-
Peifer C, Alessi DR. Small-molecule inhibitors of PDK1. Chem Med Chem 2008; 3: 1810-1838.
-
(2008)
Chem Med Chem
, vol.3
, pp. 1810-1838
-
-
Peifer, C.1
Alessi, D.R.2
-
29
-
-
28544443984
-
Promoting apoptosis as a strategy for cancer drug discovery
-
Fesik SW. Promoting apoptosis as a strategy for cancer drug discovery. Nat Rev Cancer 2005; 5: 876-885.
-
(2005)
Nat Rev Cancer
, vol.5
, pp. 876-885
-
-
Fesik, S.W.1
-
31
-
-
0036598992
-
Targeting death and decoy receptors of the tumour-necrosis factor superfamily
-
Ashkenazi A. Targeting death and decoy receptors of the tumour-necrosis factor superfamily. Nat Rev Cancer 2002; 2: 420-430.
-
(2002)
Nat Rev Cancer
, vol.2
, pp. 420-430
-
-
Ashkenazi, A.1
-
32
-
-
0036964804
-
Inositol hexaphosphate blocks tumor cell growth by activating apoptotic machinery as well as inhibiting the Akt/NFκB-mediated cell survival pathway
-
Ferry S, Matsuda M, Yoshida H, Hirata M. Inositol hexaphosphate blocks tumor cell growth by activating apoptotic machinery as well as inhibiting the Akt/NFκB-mediated cell survival pathway. Carcinogenesis 2002; 23: 2031-2041.
-
(2002)
Carcinogenesis
, vol.23
, pp. 2031-2041
-
-
Ferry, S.1
Matsuda, M.2
Yoshida, H.3
Hirata, M.4
-
33
-
-
33745221877
-
Anticarcinogenic effect of phytic acid (IP6): apoptosis as a possible mechanism of action
-
Verghese M, Rao DR, Chawan CB, Walker LT, Shackelford L. Anticarcinogenic effect of phytic acid (IP6): apoptosis as a possible mechanism of action. LWT- Food Science and Technology 2006; 39: 1093-1098.
-
(2006)
LWT- Food Science and Technology
, vol.39
, pp. 1093-1098
-
-
Verghese, M.1
Rao, D.R.2
Chawan, C.B.3
Walker, L.T.4
Shackelford, L.5
-
34
-
-
0242526048
-
Cancer inhibition by inositol hexaphosphate (IP6) and inositol: from laboratory to clinic
-
Vucenik I, Shamsuddin AM. Cancer inhibition by inositol hexaphosphate (IP6) and inositol: from laboratory to clinic. J Nutr 2003; 133: 3778S-3784S.
-
(2003)
J Nutr
, vol.133
, pp. 3778S-3784S
-
-
Vucenik, I.1
Shamsuddin, A.M.2
-
35
-
-
33750846875
-
Protection against cancer by dietary IP6 and inositol
-
Vucenik I, Shamsuddin AM. Protection against cancer by dietary IP6 and inositol. Nutr Cancer 2006; 55: 109-125.
-
(2006)
Nutr Cancer
, vol.55
, pp. 109-125
-
-
Vucenik, I.1
Shamsuddin, A.M.2
-
36
-
-
73649095931
-
Inositol Hexaphosphate Suppresses Growth and Induces Apoptosis in Prostate Carcinoma Cells in Culture and Nude Mouse Xenograft: PI3K-Akt Pathway as Potential Target
-
Gu M, Roy S, Raina K, Agarwal C, Agarwal R. Inositol Hexaphosphate Suppresses Growth and Induces Apoptosis in Prostate Carcinoma Cells in Culture and Nude Mouse Xenograft: PI3K-Akt Pathway as Potential Target. Cancer Res 2009; 69: 9465-9472.
-
(2009)
Cancer Res
, vol.69
, pp. 9465-9472
-
-
Gu, M.1
Roy, S.2
Raina, K.3
Agarwal, C.4
Agarwal, R.5
-
37
-
-
84888881066
-
Pro-apoptotic effect of rice bran inositol hexaphosphate (IP6) on HT-29 colorectal cancer cells
-
Shafie NH, Esa NM, Ithnin H, Saad N, Pandurangan AK. Pro-apoptotic effect of rice bran inositol hexaphosphate (IP6) on HT-29 colorectal cancer cells. Int J Mol Sci 2003; 14: 23545-23558.
-
(2003)
Int J Mol Sci
, vol.14
, pp. 23545-23558
-
-
Shafie, N.H.1
Esa, N.M.2
Ithnin, H.3
Saad, N.4
Pandurangan, A.K.5
-
38
-
-
15444371092
-
Nicotine inactivation of the proapoptotic function of Bax through phosphorylation
-
Xin M, Deng X. Nicotine inactivation of the proapoptotic function of Bax through phosphorylation. J Biol Chem 2005; 280: 10781-10789.
-
(2005)
J Biol Chem
, vol.280
, pp. 10781-10789
-
-
Xin, M.1
Deng, X.2
-
39
-
-
34447545513
-
Opposing effects of Bad phosphorylation at two distinct sites by Akt1 and JNK1/2 on ischemic brain injury
-
Wang XT, Pei DS, Xu J, Guan QH, Sun YF, Liu XM, Zhang GY. Opposing effects of Bad phosphorylation at two distinct sites by Akt1 and JNK1/2 on ischemic brain injury. Cell Signal 2007; 19: 1844-1856.
-
(2007)
Cell Signal
, vol.19
, pp. 1844-1856
-
-
Wang, X.T.1
Pei, D.S.2
Xu, J.3
Guan, Q.H.4
Sun, Y.F.5
Liu, X.M.6
Zhang, G.Y.7
-
40
-
-
0030793370
-
Inositol hexaphosphate inhibits cell transformation and activator protein 1 activation by targeting phosphatidylinositol-3 kinase
-
Huang C, Ma WI, Hecht SS, Dong Z. Inositol hexaphosphate inhibits cell transformation and activator protein 1 activation by targeting phosphatidylinositol-3 kinase. Cancer Res 1997; 57: 2873-2878.
-
(1997)
Cancer Res
, vol.57
, pp. 2873-2878
-
-
Huang, C.1
Ma, W.I.2
Hecht, S.S.3
Dong, Z.4
-
42
-
-
0030793370
-
Inositol hexaphosphate inhibits cell transformation and activator protein 1 activation by targeting phosphatidylinositol-3' kinase
-
Huang C, Ma WY, Hecht SS, Dong Z. Inositol hexaphosphate inhibits cell transformation and activator protein 1 activation by targeting phosphatidylinositol-3' kinase. Cancer Res 1997; 57: 2873-2878.
-
(1997)
Cancer Res
, vol.57
, pp. 2873-2878
-
-
Huang, C.1
Ma, W.Y.2
Hecht, S.S.3
Dong, Z.4
-
43
-
-
9244227660
-
Antisense and dominantnegative AKT2 cDNA inhibits glioma cell invasion
-
Pu P, Kang C, Li J, Jiang H. Antisense and dominantnegative AKT2 cDNA inhibits glioma cell invasion. Tumour Biol 2004; 25: 172-178.
-
(2004)
Tumour Biol
, vol.25
, pp. 172-178
-
-
Pu, P.1
Kang, C.2
Li, J.3
Jiang, H.4
-
44
-
-
0001457668
-
Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA
-
Cheng JQ, Ruggeri B, Klein WM, Sonoda G, Altomare DA, Watson DK, Testa JR. Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA. Proc Natl Acad Sci U S A 1996; 93: 3636-3641.
-
(1996)
Proc Natl Acad Sci U S A
, vol.93
, pp. 3636-3641
-
-
Cheng, J.Q.1
Ruggeri, B.2
Klein, W.M.3
Sonoda, G.4
Altomare, D.A.5
Watson, D.K.6
Testa, J.R.7
-
45
-
-
51049118140
-
An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer
-
Stemke-Hale K, Gonzalez-Angulo AM, Lluch A, Neve RM, Kuo WL, Davies M, Carey M, Hu Z, Guan Y, Sahin A, Symmans WF, Pusztai L, Nolden LK, Horlings H, Berns K, Hung MC, van de Vijver MJ, Valero V, Gray JW, Bernards R, Mills GB, Hennessy BT. An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer. Cancer Res 2008; 68: 6084-609.
-
(2008)
Cancer Res
, vol.68
, pp. 6084-6609
-
-
Stemke-Hale, K.1
Gonzalez-Angulo, A.M.2
Lluch, A.3
Neve, R.M.4
Kuo, W.L.5
Davies, M.6
Carey, M.7
Hu, Z.8
Guan, Y.9
Sahin, A.10
Symmans, W.F.11
Pusztai, L.12
Nolden, L.K.13
Horlings, H.14
Berns, K.15
Hung, M.C.16
van de Vijver, M.J.17
Valero, V.18
Gray, J.W.19
Bernards, R.20
Mills, G.B.21
Hennessy, B.T.22
more..
-
46
-
-
0032575714
-
Death receptors: signaling and modulation
-
Ashkenazi A and Dixit VM. Death receptors: signaling and modulation. Science 1998; 281: 1305-1308.
-
(1998)
Science
, vol.281
, pp. 1305-1308
-
-
Ashkenazi, A.1
Dixit, V.M.2
-
48
-
-
84856641109
-
NF-κB, the first quarter-century: remarkable progress and outstanding questions
-
Hayden MS, Ghosh S. NF-κB, the first quarter-century: remarkable progress and outstanding questions. Genes Dev 2012; 26: 203-34.
-
(2012)
Genes Dev
, vol.26
, pp. 203-234
-
-
Hayden, M.S.1
Ghosh, S.2
|